This article was originally published in The Gray Sheet
Executive SummaryExclusive worldwide license to Focal lung and kidney post-biopsy applications granted by Genzyme to the Biopsy Sciences subsidiary. Genzyme Biosurgery will supply materials and polymer expertise to Bio-Seal, which will manufacture and distribute any products resulting from the agreement...
You may also be interested in...
The US FDA has overhauled its ‘Purple Book’ to make it a searchable database of biologics information. The agency is also seeking input on next steps.
The International Council for Harmonisation has replaced its 1993 guideline on reproductive toxicity studies with an updated version.
Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales of around €120m.